News Blog

News Blog


Money for cheaper herb-based malaria meds

malaria, Affordable Medicines Facility for Malaria, AMFm, Global Fund to Fight AIDS, Tuberculosis and Malaria, artemisinin, Coartem A subsidy program intended to drive down the cost of lifesaving malaria drugs called artemisinin-based combination therapies—now considered the most effective treatment against the parasitic disease—was unveiled today in Norway.

The program, a partnership between nonprofits, the Global Fund to Fight AIDS, Tuberculosis and Malaria and 30 governments, could lower the cost of the treatment, whose main ingredient is a Chinese herb, to between 20 and 50 cents.

Right now, the therapy costs $6 to $10 at the roadside shops where remote villagers purchase the meds, according to the new project, the Affordable Medicines Facility for Malaria (AMFm). The first 11 countries where the discounted meds will be available are Benin, Cambodia, Ghana, Kenya, Madagascar, Niger, Nigeria, Rwanda, Senegal, Tanzania and Uganda.

“The age when the world had effective drugs against infectious diseases but let millions die each year because they couldn’t afford them is over,” Norwegian Foreign Minister Jonas Gahr Støre said in a statement launching the effort today.

The subsidy program was recommended five years ago by the Institute of Medicine (IOM), a U.S. advisory panel, as the best way to make artemisinin-based combination therapies available in poor countries where drug resistance to the Chinese herb is a threat. (One of those drugs, Coartem, was approved by the Food and Drug Administration last week for sale in the U.S; the World Health Organization has approved Coartem and several other artemisinin-combo treatments for purchase by U.N. agencies.)

Combination treatments are considered more effective than artemisinin alone, which stays in the body for only a few days. The additional med sticks around longer, destroying any remaining malaria parasites and lowering the chance that they'll develop resistance to artemisinin itself. But patients sometimes buy stand-alone forms of artemisinin because it's cheaper—a worry for public health officials concerned about resistance to the treatment.

AMFm says the subsidy ($225 million to $233 million in the first two years) also is necessary because the new artemisinin-combo drugs cost 10 to 40 times more than older ones, such as chloroquine, to which malaria has become resistant.

The U.S. isn't kicking any money into the program because of concerns that the subsidized meds are sometimes misused in patients who are feverish but don't have malaria, making such projects a waste of money, according to the New York Times. "I sometimes joke that this is the biggest faith-based initiative in the world of malaria," Bernard Nahlen, deputy coordinator of the President’s Malaria Initiative (an interagency project to expand U.S. funding of overseas malaria projects), told the newspaper. "I’m perfectly willing to be convinced, but sometimes the advocacy gets out ahead of the evidence."

An estimated 350 million to 500 million cases of malaria occur each year, killing nearly a million children annually, mostly in sub-Saharan Africa and Asia.

Read more about how the herb beats malaria in our Ask the Experts piece on artemisinin.

Image of boy waiting for malaria test results in Tanzania by DVIDSHUB via Flickr

Tags: coartem, drug resistance, artemisinin, malaria
More News Blog: Next: NIH issues new stem cell research guidelines Previous: Cell phones will thrive in Africa, but security will be a problem

2 Comments

Add Comment
View
  1. 1. Carlton22 03:32 AM 4/27/09

    Jim Humble has already found a "cure" for Malaria, Aids and just about every disease facing the African Nations and the world. But will medical authorities listen or are they more interested in profit over lives. Try this yourself. Make a 28% solution of Sodium Chlorite (NaCl02). Mix 15 drops of the solution with 1 teaspoon of either pure lemon or lime juice, or acetic acid, or 5% vinnegar and let it set for 3 minutes. This makes Chlorine Dioxide (Cl02). Now add 4 ounces of water or pure apple juice (no vitamin C added). Drink it down. Jim did this with thousands of Africans suffering with Malaria, Aids, etc., etc. and got a 100% cure rate. It even drove worms out of their bodies. Did Jim get the Noble Prize for the solution to almost every disease of man? Nope. Jim is living in hiding somewhere in Mexico or ??? Go figure.

    Reply | Report Abuse | Link to this
  2. 2. Nurse Tywonn 01:18 PM 8/22/09

    "The U.S. isn't kicking any money into the program because of concerns that the subsidized meds are sometimes misused in patients who are feverish but don't have malaria, making such projects a waste of money, according to the New York Times." In countries where malaria is prevalent, it is recommended that all fevers with an unknown cause are treated as malaria in order to save lives.

    Reply | Report Abuse | Link to this
Leave this field empty

Add a Comment

You must sign in or register as a ScientificAmerican.com member to submit a comment.
Click one of the buttons below to register using an existing Social Account.

More from Scientific American

See what we're tweeting about

Scientific American Editors

Tweets could not be retrieved at this time

Free Newsletters


Get the best from Scientific American in your inbox

Solve Innovation Challenges

Powered By: Innocentive

  SA Digital
  SA Digital

Science Jobs of the Week

Email this Article

Money for cheaper herb-based malaria meds: Scientific American Blog

X
Scientific American MIND iPad

Tap into your MIND

Get Both Print & Tablet Editions for one low price!

Subscribe Now >>

X

Please Log In

Forgot: Password

X

Account Linking

Welcome, . Do you have an existing ScientificAmerican.com account?

Yes, please link my existing account with for quick, secure access.



Forgot Password?

No, I would like to create a new account with my profile information.

Create Account
X

Report Abuse

Are you sure?

X

Institutional Access

It has been identified that the institution you are trying to access this article from has institutional site license access to Scientific American on nature.com. To access this article in its entirety through site license access, click below.

Site license access
X

Error

X

Share this Article

X

About the Bering in Mind Blog

In this column presented by Scientific American Mind magazine, research psychologist Jesse Bering of Queen's University Belfast ponders some of the more obscure aspects of everyday human behavior. Ever wonder why yawning is contagious, why we point with our index fingers instead of our thumbs or whether being breastfed as an infant influences your sexual preferences as an adult? Get a closer look at the latest data as "Bering in Mind" tackles these and other quirky questions about human nature. Sign up for the RSS feed or friend Dr. Bering on Facebook and never miss an installment again.

X

About the Cross-check Blog

Every week, John Horgan takes a puckish, provocative look at breaking science. A former staff writer at Scientific American, he is the author of several books—most notably, The End of Science: Facing the Limits of Knowledge in the Twilight of the Scientific Age. He currently directs the Center for Science Writings at Stevens Institute of Technology. He lives in New York State's Hudson Highlands, where he plays ice hockey each winter to hone his cross-checking skills.

X

Expeditions Blog

Ever wonder what it's really like to be working in Antarctica or collecting core samples from the middle of the Pacific Ocean? Get a first-hand feel for scientific exploration by following the blog posts of researchers out in the field.

X

About the Extinction Countdown Blog

Several times a week, John Platt shines a light on endangered species from all over the globe, exploring not just why they are dying out but also what's being done to rescue them from oblivion. From unusual or little-known organisms like the giant spitting earthworm and the stinking hawk's-beard to popular favorites like cheetahs and koalas, Platt, a journalist specializing in environmental issues and technology, does his part to slow the countdown.

X

About the Guest Blog

The editors of Scientific American regularly encounter perspectives on science and technology that we believe our readers would find thought-provoking, fascinating, debatable and challenging. The guest blog is a forum for such opinions. The views expressed belong to the author and are not necessarily shared by Scientific American.

X

About the Solar at Home Blog

Follow Scientific American editor George Musser as he installs--or tries to install--solar photovoltaic panels on the roof of his suburban New Jersey home. You'll learn the literal nuts and bolts of going green with the sun and get energy-saving tips even if you aren't putting up panels.

Write to us with tips or comments at blog@sciam.com and follow us on Twitter: http://twitter.com/sciam.

X